Ajax Therapeutics

company

About

Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$40M
Industries
Biotechnology,Life Science,Medical
Founded date
Jan 1, 2019
Operating Status
Active

Ajax Therapeutics is an NYC-based biotechnology company applying computational chemistry and structure-based technologies to develop novel small molecules for hematologic malignancies

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$40M
Ajax Therapeutics has raised a total of $40M in funding over 2 rounds. Their latest funding was raised on Jun 1, 2021 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 1, 2021 Series Unknown $40M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
Ajax Therapeutics is funded by 2 investors. Schrödinger and Inning One Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Schrödinger Series Unknown
Inning One Ventures Series Unknown